Roles
- Associate Professor of Clinical Neurology
- Chief of Neurology, Jackson South and Jackson West Medical Centers
- Director, Stroke Program, Jackson South Medical Center
-
Biography
Dr. Gillian Gordon Perue is an Associate Professor of vascular neurology at the Leonard M Miller School of Medicine University of Miami and serves as Chief of Neurology and Medical Director of the stroke program for 2 hospitals: Jackson South, and Jackson North Medical Centers. She also serves as the Associate Program Director for Resident Research.
Dr. Gordon Perue is a proud alumnus of the University of the West Indies where she began her medical career in Jamaica; she was one of only three persons that year to graduate MBBS with honors and was Class Valedictorian. She went on to complete an internship, a Residency and Doctorate in Internal Medicine before she migrated to the USA. Once in the USA, Dr. Gordon Perue completed a second residency in Neurology at the University of Miami. There she earned the role of Research Chief Resident. In this role, she created and established the UM Neurology Resident Research Day which is now an endowed research training program. Dr. Gordon Perue then furthered her expertise in the care of patients with Cerebrovascular disease through a Stroke Fellowship, also at the University of Miami.
She is the first author on multiple publications, has co-authored numerous publications, she speaks both locally and internationally, has been a moderator at the International Stroke Conference and the American Academy of Neurology. She is a recognized fellow of the American Academy of Neurology, Fellow of the American Heart Association and member of the WSO Stroke Implementation Taskforce -
Education & Training
Education
Post Graduate Training
-
Teaching Interests
In her current role as a Co-Investigator and Director of the Education and Training Core of the Florida Stroke Registry, she works along with the Florida Department of Health and the CDC’s Paul Coverdell grant to influence the stroke systems of care across the state of Florida. -
Research Interests
Her research focuses on ensuring equality of care for all with hypertension and post stroke. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Ralph L. Sacco Research Day Highlights Next Generation of Neurology Investigators
International Stroke Conference 2026: Miller School of Medicine Neurologists Highlight New Stroke Guidelines and Data-Driven Innovations
Miller School Scientists Earn Prestigious Basic Research, New Investigator Awards at 2025 International Stroke Conference
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
To identify a dose of TS23 that is safe and more efficacious than placebo for the treatment of patients from 4.5 to 24 hours of acute ischemic stroke onset (or last known well).
- Principal Investigator: Gillian Gordon-Perue
- Study Phase: TBD
- Enrollment Status: Open
-
To identify a dose of TS23 that is safe and more efficacious than placebo for the treatment of patients from 4.5 to 24 hours of acute ischemic stroke onset (or last known well).
- Principal Investigator: Gillian Gordon-Perue
- Study Phase: TBD
- Enrollment Status: Open
